Close

Elena Verdú, MD, PhD

Professor, Department of Medicine

Canada Research Chair in Inflammation, Microbiota and Nutrition

Director of the Axenic Gnotobiotic Unit

Email: verdue@mcmaster.ca

Lab web site: www.verdulab.ca

Research Areas

I am interested in the pathogenesis of chronic inflammatory disorders such as celiac disease and inflammatory bowel disease. I investigate dietary-bacterial interactions and how this impacts the pathogenesis of gastrointestinal disease, with the view to develop novel therapeutic strategies for these disorders.

Focus

The main focus of research is to study host-microbial and dietary interactions and their role in the pathophysiology of chronic gastrointestinal inflammatory diseases. Work in my lab deals with the way commensal bacteria and food components interact with host tissues to enhance or prevent susceptibility to inflammation. We use a variety of molecular, mouse humanized models and clinical translational approaches to determine whether and how gluten-induced immunopathology is modulated by the small intestinal microbiota. Another important research interest investigates the role of the intestinal microbiota in the induction of mucosal barrier dysfunction and immune responses in the host that are of relevance in inflammatory bowel disease development. As director of the Axenic Gnotobiotic Facility at McMaster, we rederive transgenic mouse strains of interest to perform gnotobiotic colonizations using clinical isolates. The long term goal is to identify novel therapeutic targets to treat celiac disease and inflammatory bowel disease.

  1. Verdu, EF, Danska, JS. Common ground: shared risk factors for type 1 diabetes and celiac disease. Nat. Immunol. 2018; :. doi: 10.1038/s41590-018-0130-2. PubMed PMID:29925984 .
  2. Libertucci, J, Dutta, U, Kaur, S, Jury, J, Rossi, L, Fontes, ME et al.. Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease. Am. J. Physiol. Gastrointest. Liver Physiol. 2018; :. doi: 10.1152/ajpgi.00411.2017. PubMed PMID:29848021 .
  3. Meisel, M, Hinterleitner, R, Pacis, A, Chen, L, Earley, ZM, Mayassi, T et al.. Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature. 2018;557 (7706):580-584. doi: 10.1038/s41586-018-0125-z. PubMed PMID:29769727 .
  4. Miranda, PM, De Palma, G, Serkis, V, Lu, J, Louis-Auguste, MP, McCarville, JL et al.. High salt diet exacerbates colitis in mice by decreasing Lactobacillus levels and butyrate production. Microbiome. 2018;6 (1):57. doi: 10.1186/s40168-018-0433-4. PubMed PMID:29566748 PubMed Central PMC5865374.
  5. McCarville, JL, Dong, J, Caminero, A, Bermudez-Brito, M, Jury, J, Murray, JA et al.. A commensal strain improves gluten-related immunopathology in mice through expression of a serine protease inhibitor. Appl. Environ. Microbiol. 2017; :. doi: 10.1128/AEM.01323-17. PubMed PMID:28778891 PubMed Central PMC5601352.
  6. Pinto-Sánchez, MI, Causada-Calo, N, Bercik, P, Ford, AC, Murray, JA, Armstrong, D et al.. Safety of Adding Oats to a Gluten-Free Diet for Patients With Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies. Gastroenterology. 2017;153 (2):395-409.e3. doi: 10.1053/j.gastro.2017.04.009. PubMed PMID:28431885 .
  7. Thevaranjan, N, Puchta, A, Schulz, C, Naidoo, A, Szamosi, JC, Verschoor, CP et al.. Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction. Cell Host Microbe. 2017;21 (4):455-466.e4. doi: 10.1016/j.chom.2017.03.002. PubMed PMID:28407483 PubMed Central PMC5392495.
  8. Verdu, EF, Caminero, A. How infection can incite sensitivity to food. Science. 2017;356 (6333):29-30. doi: 10.1126/science.aan1500. PubMed PMID:28385972 .
  9. Bai, JC, Verdú, EF. The CD That Pays Dividends: More Than 15 Years of Deamidated Gliadin Peptide Antibodies. Dig. Dis. Sci. 2017;62 (5):1110-1112. doi: 10.1007/s10620-017-4528-8. PubMed PMID:28315033 .
  10. De Palma, G, Lynch, MD, Lu, J, Dang, VT, Deng, Y, Jury, J et al.. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci Transl Med. 2017;9 (379):. doi: 10.1126/scitranslmed.aaf6397. PubMed PMID:28251905 .
Search PubMed
Share on FacebookTweet about this on TwitterShare on Google+Share on LinkedIn